ArticleEuropean journal of internal medicine2023
Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients.
Stefania Piconi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.